Back to Journals » International Medical Case Reports Journal » Volume 18
Herpes Zoster of the Sacral Region without Motor Dysfunction in a 55-year-Old Female: A Case Report and Literature Review
Authors Alsulaiman OA , Alsaati AA , Alsulaiman F , Aljaafari D, Alabdali M
Received 28 February 2025
Accepted for publication 28 May 2025
Published 3 June 2025 Volume 2025:18 Pages 677—682
DOI https://doi.org/10.2147/IMCRJ.S525433
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Thomas E Hutson
Omer A Alsulaiman,1 Ahmed Abdulaziz Alsaati,2 Feras Alsulaiman,3 Danah Aljaafari,3 Majed Alabdali3
1Department of Dermatology, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia; 2Department of Internal Medicine, Jubail General Hospital, Jubail, Saudi Arabia; 3Department of Neurology, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia
Correspondence: Omer A Alsulaiman, Department of Dermatology, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, 34222, Saudi Arabia, Email [email protected]
Abstract: Herpes zoster infection, commonly known as shingles, typically involves the thoracic and lumbar dermatomes. Sacral involvement is rare, occurring in only 4– 8% of cases. This report presents a 55-year-old female with herpes zoster affecting the S1 dermatome, manifesting as burning pain and clustered vesicles on her right leg, without motor dysfunction or urinary symptoms. A clinical diagnosis was made based on a characteristic unilateral S1 dermatomal vesicular eruption. Despite the rarity of sacral herpes zoster without motor involvement, the patient responded well to antiviral treatment and neuropathic pain management, with no complications noted in the long-term follow-up. This case highlights the necessity for clinicians to consider sacral herpes zoster in patients with radicular pain to prevent misdiagnosis.
Keywords: herpes zoster, sacral dermatome, radiculopathy, shingles, neuropathic pain
Introduction
Varicella, commonly referred to as chickenpox, is a contagious disease caused by primary infection with varicella-zoster virus (VZV). Following primary infection, the virus remains latent in the sensory and autonomic ganglia. Complications are more frequent in geriatric and immunocompromised individuals, although primary varicella in older adults is rare.1
Herpes zoster (HZ) infection, also known as shingles, is caused by reactivation of the VZV. Reactivation typically occurs due to an age-related decline in immunity or immunosuppression, although HZ can also manifest in healthy individuals.2–4 Clinically, HZ is characterized by a painful, unilateral rash distributed along a single dermatome in patients with prior varicella infection.5 A common complication of HZ is post-herpetic neuralgia, defined as persistent pain lasting >3 months after the rash has healed.3 HZ most frequently affects the thoracic and lumbar dermatomes; involvement of the sacral nerves is relatively rare, occurring in only 4–8% of cases.4,6,7 In cases where the sacral nerves are affected, patients may experience sensory and motor deficits that affect the bladder and bowel, potentially resulting in urinary dysfunction, incontinence, or constipation.6,8,9 This report presents a rare case of sacral HZ localized to the S1 dermatome, accompanied by significant burning pain but without motor dysfunction.
Case Presentation
A 55-year-old woman (weight: 100 kg, height: 160 cm, body mass index: 39.06 kg/m2 (classified as class II morbid obesity)) presented to the Neurology Clinic with an aching pain that had begun 4 days prior to her visit. The pain primarily affected her right leg, extending from the lower back to the base of her foot. Described as continuous, progressive, and burning (particularly in her toes), the pain lasted approximately 2 weeks from its onset. A cluster of vesicles appeared on the lateral side of her right leg, extending to the gluteal region; these tender lesions had developed 1 day before her clinic visit and had persisted for 10 days. She also reported muscle weakness, itching, intermittent numbness, tingling, and loss of sensation in her right leg, which had initially been masked by the pain but became more apparent as the pain subsided. The patient had no known contact with sick individuals, no history of similar symptoms, and had neither taken new medications nor received immunosuppressive treatments. She had not been hospitalized for any serious illness and had no recent infections. Therefore, her immunological status was intact, with no evidence of immunosuppression. She denied any constitutional symptoms, and her only additional complaint was lower back pain. The pain had begun to interfere with her daily life, making it difficult to sit or walk on some occasions. As a result, she arrived at the clinic in a wheelchair.
Her medical history revealed attempts to reduce her weight through dieticians, restrictive diets, and exercise; however, this had been unsuccessful. Despite her morbid obesity, she did not present with any obesity-related complications and was not on any chronic medications. Notably, she had received the varicella-zoster vaccine during childhood. The patient was employed as a teacher but reported no significant recent stressors aside from typical daily pressures.
A physical examination showed clustered vesicles on an erythematous base extending unilaterally along the S1 dermatome from the lateral side of her right leg to the dorsolateral aspect of her right foot (Figures 1 and 2). These vesicles were tender to touch. A neurological examination revealed localized pain in the S1 dermatome, with no voiding dysfunction, hyperesthesia, or allodynia. The fine touch assessment showed a loss of sensation over the S1 dermatome, and proprioception was impaired in the distal digits of her right foot. In contrast, sensations and proprioception were intact in the contralateral side. The patient was afebrile, and her general examination was otherwise unremarkable.
Laboratory investigations showed mild anemia (hemoglobin: 11.4 g/dL), elevated low-density lipoprotein cholesterol (132 mg/dL), and vitamin D deficiency (20.6 ng/mL). Other parameters, including complete blood count (CBC), liver function tests (LFT), renal function tests (RFT), serological tests, and hemoglobin A1c, were within normal limits. Magnetic resonance imaging (MRI) of the lumbar spine, conducted for previous lower back pain, showed disc bulges at L3–L4 and L4–L5, partially encroaching on the corresponding exit foramina. Electromyography and nerve conduction studies were normal, ruling out any motor or sensory conduction abnormalities.
Based on her clinical presentation and the exclusion of other differential diagnoses, the patient was diagnosed with sacral (S1) HZ infection.
The treatment plan included oral acyclovir 400 mg every 8 h for 10 days, acyclovir cream applied topically to the affected area twice daily for 10 days, vitamin D3 50,000 IU weekly, calcium carbonate 600 mg once daily, and gabapentin 800 mg twice daily for 1 month. She was also counseled on the benefits of a weight-reduction diet and the potential benefits of physiotherapy for her lower back pain.
During her first follow-up visit, 7 days after starting treatment, the patient showed improvements, with reduced pain and resolution of the vesicles. She arrived using a cane instead of a wheelchair, as her pain intensity had decreased, although the loss of sensation in her right leg had become more prominent.
At her 1-month follow-up, conducted via a telephone call, the patient reported complete resolution of both pain and vesicles within 10 days of treatment initiation. Sensory symptoms, including tingling, numbness, and muscle weakness, had also subsided within 10 days. Notably, the sensation in her right foot took longer to recover than her thigh and shin. No complications, such as post-herpetic neuralgia, were observed during the follow-up period, and she continued to regain sensation gradually. The patient provided written informed consent for the publication of this case report and its associated figures.
Discussion
HZ infection, commonly referred to as shingles, is caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox (varicella). Following the initial infection, typically during childhood, the virus becomes latent in the dorsal root ganglia and can reactivate later in life, particularly in elderly or immunocompromised individual.10,11 Although stressors, such as fever, trauma, or emotional disturbances, can increase the likelihood of reactivation, the primary mode of transmission for the varicella-zoster virus is through aerosolized droplets or direct contact with lesions. Once reactivated, the virus replicates and travels along sensory nerves, producing the clinical manifestations of HZ.
The typical presentation involves dermatomal radiculopathy, which is characterized by paresthesia, radiating pain, and the formation of painful vesicular lesions that are confined to a single dermatome.2,10,12 While HZ can affect any sensory ganglion, it most commonly involves the thoracic dermatomes (56%), followed by the cranial, lumbar, and cervical dermatomes (11, 13, 11%, respectively), with sacral involvement being particularly rare, affecting only 4% of patients.13 Sacral HZ is frequently associated with urinary dysfunction and bowel complications due to its involvement in the sensory and motor innervation of these systems.14,15
Table 1 presents a compilation of documented cases of rare sacral HZ. Due to its rarity, sacral HZ may be overlooked by clinicians, particularly when its symptoms are similar to those of other conditions. For example, a case report by Hung et al described a patient with sacral HZ who initially presented with symptoms of sciatic pain and weakness following a traffic collision. The initial diagnosis was a sacral fracture; however, this was later revised upon the appearance of vesicular lesions along the S1 dermatome. Only the subsequent appearance of vesicular lesions along the S1 dermatome served to confirm the diagnosis of HZ.16 Furthermore, it has been demonstrated that trauma increases the risk of HZ at the site of injury by a factor of 12,17 thereby further complicating the diagnosis in cases of recent physical trauma.16,18
![]() |
Table 1 Reported Case Studies in the Literature |
In contrast to the case described by Hung et al, the present case of sacral HZ occurred without any preceding trauma or stressor; therefore, this diagnosis was primarily based on the presentation of burning pain and vesicular lesions following the S1 dermatome. Despite the involvement of the sacral nerves, the patient did not develop neurogenic bladder or voiding dysfunction, with pain being the primary complaint.
This case report is limited by its clinical diagnosis without polymerase chain reaction confirmation of VZV, a short 1-month follow-up period, and lack of formal autonomic testing. However, the classic S1 dermatomal rash, normal MRI and nerve conduction studies to exclude other causes, and complete resolution of symptoms support the validity of our observations without affecting patient care.
Conclusion
Skin examinations are of great importance, yet frequently underappreciated, in diagnosing conditions such as sacral HZ. In this case, the early recognition of dermatological signs was crucial in reaching an accurate diagnosis. Physicians should consider sacral HZ as a potential differential diagnosis for patients presenting with acute radiculopathy, particularly when other causes have been excluded.
Ethical Statement
The study was approved by the Institutional Review Board of Imam Abdulrahman Bin Faisal University on on July 22, 2024 (IRB-PGS-2024-01-550), and we confirm that institutional approval was required for publication of the case details.
Funding
There is no funding to report.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Rahmi AM, Prakasita KA, Damayanti D. Varicella challenges: a case of respiratory tract complications in an elderly patient. Narra J. 2024;4(3):e1150. doi:10.52225/narra.v4i3.1150
2. Oxman MN. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence. J Am Osteopath Assoc. 2009;109(suppl 62):S13–S17.
3. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274–280. doi:10.4065/84.3.274
4. Chiriac A, Chiriac AE, Naznean A, Moldovan C, Podoleanu C, Stolnicu S. Sacral (S1) herpes zoster. J Pain Res. 2019;12:1475–1477. doi:10.2147/JPR.S199124
5. Cohen EJ, Jeng BH. Herpes zoster: a brief definitive review. Cornea. 2021;40(8):943–949. doi:10.1097/ICO.0000000000002754
6. Hur J. Sacral herpes zoster associated with voiding dysfunction in a young patient with scrub typhus. Infect Chemother. 2015;47(2):133–136. doi:10.3947/ic.2015.47.2.133
7. Fatahajjad HH, Soebadi MA, Putra RM, Sulastri N, Rahaju AS. Effect of moderate-intensity aerobic exercise on bladder TGF-β1 and type I collagen expressions in diabetic rat model. Narra J. 2024;4(3):e1110. doi:10.52225/narra.v4i3.1110
8. Broseta E, Osca JM, Morera J, Martinez-Agullo E, Jimenez-Cruz JF. Urological manifestations of herpes zoster. Eur Urol. 1993;24(2):244–247. doi:10.1159/000474302
9. Richmond W. The genito-urinary manifestations of herpes zoster. Three case reports and a review of the literature. Br J Urol. 1974;46(2):193–200. doi:10.1111/j.1464-410x.1974.tb03743.x
10. Alikhan A, Hocker TLH. Review of Dermatology. Edinburgh: Elsevier, Incorporated; 2017.
11. Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14(2):192. doi:10.3390/v14020192
12. Bhushan S, Dominguez L, Shirazi E, Gupta V. Acute herpes zoster radiculopathy of the lower extremity with dermatomal rash and lumbar nerve enhancement on MRI. Mayo Clin Proc Innov Qual Outcomes. 2020;4(5):608–610. doi:10.1016/j.mayocpiqo.2020.06.001
13. Carbone V, Leonardi A, Pavese M, Raviola E, Giordano M. [Herpes zoster of the trigeminal nerve: a case report and review of the literature]. Minerva Stomatol. 2004;53(1–2):49–59. Estonian
14. Chen PH, Hsueh HF, Hong CZ. Herpes zoster-associated voiding dysfunction: a retrospective study and literature review. Arch Phys Med Rehabil. 2002;83(11):1624–1628. doi:10.1053/apmr.2002.34602
15. Park BS, Kim JI, Lee SJ. Comparison of recovery periods according to treatment modalities in zoster-associated voiding dysfunction. J Korean Continence Soc. 2007;11(1):36–40. doi:10.5213/jkcs.2007.11.1.36
16. Hung MH, Kuo JR, Huang KF, Wang WC. Sacral herpes zoster presenting as sciatica. CMAJ. 2010;182(11):E534. doi:10.1503/cmaj.091534
17. Thomas SL, Wheeler JG, Hall AJ. Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ. 2004;328(7437):439. doi:10.1136/bmj.37991.511829.F7
18. Ekmekyapar M, Ekmekyapar T, Oğuztürk H, Gürbüz Ş, Gökçe H. A case report: herpes zoster with sacral involvement. Eurasian J Crit Care. 2020;2:159–160.
19. Dave S, Singh-Ranger D, Garbos M, Thangiah R, Vivekanadan S. Sacral herpes zoster: a treatable cause for faecal incontinence. Clin Surg. 2022;7:3553.
20. Nishiyama D, Yoshimura S, Shimizuhira C, Ikeda N, Miyamae N, Sumida Y. Elsberg syndrome caused by herpes zoster in the sacral region with preceding urinary retention. Acute Med Surg. 2023;10(1):e824. doi:10.1002/ams2.824
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles

Efficacy and Safety of Pulsed Radiofrequency in Herpes Zoster Related Trigeminal Neuralgia: A Systematic Review and Meta-Analysis
Wang C, Dou Z, Yan M, Wang B
Journal of Pain Research 2023, 16:341-355
Published Date: 2 February 2023
A Case Report of Herpes Zoster After Botulinum Toxin Injections
Zari S
International Medical Case Reports Journal 2024, 17:261-263
Published Date: 29 March 2024
Herpes Zoster in Pregnancy: Clinical Outcomes and Treatment Patterns from a Multicenter Retrospective Cohort
Xu H, Qin X, Feng Z, You S
Journal of Pain Research 2025, 18:1817-1826
Published Date: 4 April 2025
No Genetic Causal Relationship between COVID-19 and Herpes Zoster: A Bidirectional Mendelian Randomization Analysis
Cao Y, Hu X, Li J, Zheng Y
Journal of Multidisciplinary Healthcare 2025, 18:2957-2967
Published Date: 27 May 2025